GenesisCare, a specialist in complex cancers, has confirmed plans to establish a new, state-of-the-art, comprehensive oncology and haematology centre in Leeds in northern England. This new facility will be the 15th and largest centre in its UK network.

The centre will have the ability to personalise radiotherapy in real time, using both MRI and CT imaging, offering patients treatment precisely tailored to their specific cancer. This will establish GenesisCare in Leeds as one of a small group of cancer centres worldwide with the ability to provide adaptive radiotherapy for every patient who would benefit from this approach.

Dr Eliot Sims, Chief Medical Officer at GenesisCare, explained: “Adaptive radiotherapy represents a transformative advancement in cancer treatment. By using the technology’s ability to provide live images of both the tumour and normal tissue, we can create a new treatment plan every day based on the patient’s anatomy. This gives our clinicians the confidence to deliver high-dose radiotherapy with exquisite precision, whilst minimising side effects, thereby improving patient outcomes. This is truly personalised radiotherapy.”

Set to open in early 2026, the centre will offer cancer care to insured and self-funding patients in the north of England and Scotland, who previously had to travel to GenesisCare in Oxford or London for the same treatment.

Justin Hely, GenesisCare’s CEO of UK and Europe, commented on the announcement: “For patients in the north of England, this new facility will mean access to the latest advancements in both radiotherapy and systemic therapy right on their doorstep.”

Earlier this year, GenesisCare UK signed a four-year deal with Bupa.